Small-molecule inhibitors of TBK1 serve as an adjuvant for a plasmid-launched live-attenuated yellow fever vaccine

.

Source: Human Vaccines and Immunotherapeutics - June 22, 2020 Category: Allergy & Immunology Authors: Sapna Sharma Michael A. Schmid Lorena Sanchez Felipe Jana Grenelle Suzanne J.F. Kaptein Lotte Coelmont Johan Neyts Kai Dallmeier Source Type: research